Aim: Macao Cancer Registry was established in 2003. It is population-based and has been collecting cancer reports from all possible settings where pathological and management services are available. To get a better idea over the prognosis and survival of all and major cancer sites, a survival analysis was here performed to estimate the relative survival rates of cancers diagnosed and registered during 2003 to 2005 with a follow-up of vital status till 31 Dec, 2008.
Methods: 3,244 cancer cases diagnosed and registered during 2003-2005 in Macao Cancer Registry were considered for analysis. Cases of in-situ carcinoma, extreme age and poor data quality were deliberately excluded, leaving 2,623 newly diagnosed cancers eligible. Vital status of registered cases through 31 December 2008 was confirmed by matching with death certificates and review from the Hospital Information System (HIS) of the only public hospital. Observed survival rates were calculated using a Life Table method, and relative survival rates were examined using an algorithm written in SAS by Paul Dickman with minor adaptations. Apart from general relative survival rates, specific rates by sex and age strata were also estimated.
Results: 3-year and 5-year relative survival rates of all cancers were 61% and 56% respectively for both sexes; (54% and 47%, respectively, for males and 68% and 64%for females). The 3-year relative survival rates for major cancer sites ranged from 21% to 90%, with lung cancer showing the lowest and female breast cancer the highest. 5-year relative survival rates for major cancer sites ranged from 18% to 85%, with liver cancer showing the lowest and again female breast cancer the highest. Female cancer patients had higher relative survival than males across the 5-year follow up period, with a sex difference of nearly 15%.
Conclusion: Comparison of survival rates from this first trial in Macao, deriving survival statistics from population-based cancer registration, with other Asian countries/cities, like Taiwan, Singapore and Japan, showed Macao and Taiwan to have the closest estimates for 3-year relative survival. Random variation was found to exist in the stratification of sex and age in certain cancer sites due to scarce case numbers in the subgroups. It is important to note that the 3-year survival rates are relatively more consistent and reliable than 4-year or 5-year ones. Promotion of reporting cancer stage by physicians as well as improvement in data quality of cancer registration are essential to allow further informative statistics derived from the cancer registry with reference to cancer prevention.
Download full-text PDF |
Source |
---|
J Surg Res
January 2025
Department of Pediatric Surgery, Phoenix Children's Hospital, Phoenix, Arizona. Electronic address:
Introduction: Pediatric liver transplantation provides substantial survival benefit. An emphasis on value-based practices has become a central theme in many surgical fields, but have not been well-studied in pediatric transplantation. Given an increasing focus on optimizing outcomes while containing costs, defining value in pediatric liver transplantation warrants investigation.
View Article and Find Full Text PDFMedicine (Baltimore)
January 2025
Department of Orthopedics, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, China.
This study compares and investigates the efficacy of 2 different surgical methods for early stage femoral head necrosis and analyze the factors affecting surgical outcomes and long-term femoral head survival. A retrospective analysis was conducted on the clinical data of 48 patients (52 hips) with femoral head necrosis who underwent either the Super-Path or Watson-Jones approach from January 1, 2016, to January 1, 2024. Harris scores at multiple time points before and after surgery were compared using repeated-measures analysis of variance (ANOVA), and a COX proportional hazards model was used to analyze risk factors.
View Article and Find Full Text PDFMedicine (Baltimore)
January 2025
Department of Hepatobiliary Surgery, The Third Central Hospital of Tianjin, Tianjin, China.
Background: In patients with advanced hepatocellular carcinoma (HCC) following sorafenib failure, regorafenib has been used as an initial second-line drug. It is unclear the real efficacy and safety of sorafenib-regorafenib sequential therapy compared to placebo or other treatment (cabozantinib or nivolumab or placebo) in advanced HCC.
Methods: Four electronic databases (PubMed, Embase, Web of Science, and Ovid) were systematically searched for eligible articles from their inception to July, 2024.
Medicine (Baltimore)
January 2025
Shanxi Provincial Integrated TCM and WM Hospital, Taiyuan, China.
Rationale: Local anesthesia is a widely used technique for emergency wound closure, with lidocaine among the most commonly employed local anesthetics. Allergic reactions to lidocaine are rare, with anaphylaxis being even more uncommon.
Patient Concerns And Diagnosis: This report describes a 72-year-old male patient who presented with a right foot injury and underwent wound suturing under lidocaine local anesthesia.
PLoS One
January 2025
Department of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Background: The role of adjuvant radiotherapy in pancreatic cancer following radical surgery remains a subject of of controversy. This study aimed to more accurately screen pancreatic patients who benefit from adjuvant radiotherapy.
Methods: Clinicopathologic characteristics of patients with resectable pancreatic cancer were collected from the Surveillance, Epidemiology, and End Results (SEER) database (2004-2015).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!